Obstetrics
Article
Which birth defects are associated with childhood cancer risk?
Conference Coverage
Early pregnancy loss and abortion: Medical management is safe, effective
NASHVILLE, TENN. – Medical management of elective abortion and early pregnancy loss is safe, effective, and well accepted by patients through at...
Expert Commentary
How do new BP guidelines affect identifying risk for hypertensive disorders of pregnancy?
An analysis of blood pressure (BP) data from 8,899 nulliparous women, based on recently redefined lower threshold categories of...
From the Journals
Preeclampsia doubles risk of postpartum transfusion reactions
The findings suggest that heightened attention should be paid when women with preeclampsia are evaluated for blood transfusions post partum.
News from the FDA/CDC
U.S. infant mortality continued slow decline in 2017
Massachusetts had the nation’s lowest rate; Mississippi had the highest.
From the Journals
Placental bacteria not linked to adverse pregnancy outcomes
But the researchers found significant associations between delivery-associated vaginal bacteria and preeclampsia and preterm birth.
Conference Coverage
Second trimester fetal loss: Shared decision-making, patient preference are key
Provider-driven decisions are often based on what the provider might do in the same situation, but that may not be what the patient wants.
Commentary
Fetal alcohol exposure overlooked again?
Ask pregnant women this question: “When did you realize you were pregnant and were you doing any social drinking before you knew?” Dr. Carl C....
News
U.S. fertility rate, teen births are on the decline
The report from the Centers for Disease Control and Prevention also found an increase in vaginal births after previous cesarean delivery.
News
Postpartum care: State scorecard for Medicaid enrollees
Medicaid enrollees in New Hampshire are the most likely to have a timely visit after delivery.
From the Journals
USPSTF updates, reaffirms recommendation for HBV screening in pregnant women
There have been improvements in maternal HBV therapy since the original 2009 USPSTF recommendation.